OTCMKTS:EVTCY - Evotec Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$46.15 0.00 (0.00 %)
(As of 02/18/2019 12:34 PM ET)
Previous Close$46.15
Today's Range$46.15 - $46.15
52-Week Range$29.4750 - $52.50
Volume2 shs
Average Volume288 shs
Market Capitalization$3.39 billion
P/E Ratio128.19
Dividend YieldN/A
Beta1.13
Evotec AG provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company operates through two segments, EVT Execute and EVT Innovate. It offers drug discovery services, such as integrated services, target identification and validation, hit identification, compound management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, cell and protein production, and in vivo and in vitro pharmacology services, as well as absorption, distribution, metabolism, excretion, and toxicity services. The company is also involved in investing and developing proprietary assets, including early-stage discovery programs, as well as advanced drug candidates in the areas of diabetes and diabetic complications, inflammatory diseases, neuroscience, oncology, and pain and anti-infective. It has a drug discovery and development partnerships with Celgene Corporation; Novo Nordisk A/S; Sanofi; Almirall, S.A.; Ferring Pharmaceuticals; Centogene AG; Immuneering Corporation; and LEO Pharma A/S. Evotec AG was founded in 1993 and is headquartered in Hamburg, Germany.

Receive EVTCY News and Ratings via Email

Sign-up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:EVTCY
CUSIPN/A
Phone49-4056-0810

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$291.02 million
Cash Flow$0.7244 per share
Book Value$5.11 per share

Profitability

Net Income$27.41 million

Miscellaneous

Employees2,178
Market Cap$3.39 billion
OptionableNot Optionable

Evotec (OTCMKTS:EVTCY) Frequently Asked Questions

What is Evotec's stock symbol?

Evotec trades on the OTCMKTS under the ticker symbol "EVTCY."

When is Evotec's next earnings date?

Evotec is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Evotec.

What is the consensus analysts' recommendation for Evotec?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evotec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evotec.

Has Evotec been receiving favorable news coverage?

News coverage about EVTCY stock has been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Evotec earned a news sentiment score of 1.6 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future.

Who are some of Evotec's key competitors?

Who are Evotec's key executives?

Evotec's management team includes the folowing people:
  • Dr. Werner Lanthaler, CEO & Member of Management Board (Age 51)
  • Mr. Enno Spillner, CFO & Member of Management Board (Age 49)
  • Dr. Cord Dohrmann, Chief Scientific Officer & Member of Management Board (Age 55)
  • Dr. Craig Johnstone, COO & Member of Management Board
  • Ms. Anja Bosler, Principal Accounting Officer and Sr. VP of Group Accounting

How do I buy shares of Evotec?

Shares of EVTCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evotec's stock price today?

One share of EVTCY stock can currently be purchased for approximately $46.15.

How big of a company is Evotec?

Evotec has a market capitalization of $3.39 billion and generates $291.02 million in revenue each year. The company earns $27.41 million in net income (profit) each year or $0.36 on an earnings per share basis. Evotec employs 2,178 workers across the globe.

What is Evotec's official website?

The official website for Evotec is http://www.evotec.com.

How can I contact Evotec?

Evotec's mailing address is Manfred Eigen Campus Essener Bogen 7, Hamburg 2M, 22419. The company can be reached via phone at 49-4056-0810 or via email at [email protected]


MarketBeat Community Rating for Evotec (OTCMKTS EVTCY)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  238
MarketBeat's community ratings are surveys of what our community members think about Evotec and other stocks. Vote "Outperform" if you believe EVTCY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVTCY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Featured Article: Institutional Investors

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel